Lars Abrahmsén

机构：APR Technologies (Sweden)

发表论文 106 篇 · 总被引 8471 次 · h-index 51

代表论文

• Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation (2017 · Nature Communications · 被引 330)
• Structural basis for high-affinity HER2 receptor binding by an engineered protein (2010 · Proceedings of the National Academy of Sciences · 被引 238)
• Engineering of a femtomolar affinity binding protein to human serum albumin (2008 · Protein Engineering Design and Selection · 被引 238)
• Design of an Optimized Scaffold for Affibody Molecules (2010 · Journal of Molecular Biology · 被引 188)
• Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain (2010 · Journal of Biological Chemistry · 被引 175)
• Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy (2016 · Frontiers in Oncology · 被引 137)